Search Results for: Esperion Announces Initiation of Phase
Articles
March 17, 2017
Esperion Announces Initiation of Phase II Triplet Oral Therapy Study March 17, 2017
Esperion Therapeutics, Inc., the lipid management company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the...
